If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Trulicity ® (dulaglutide) injection
0.75 mg/0.5 mL, 1.5 mg/0.5 mL, 3mg/0.5mL, 4.5mg/0.5mLThis information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Dulaglutide is a human GLP-1 RA for once-weekly administration.1
If a dulaglutide dose is missed, the next dose depends on the remaining schedule (Table 1).1
Table 1. Instructions for a Missed Dose of Dulaglutide1
|
If a dose of dulaglutide is missed and there are… |
Then… |
And... |
|
at least 72 hours until the next scheduled dose |
it should be administered as soon as possible |
patients can resume their regular once-weekly dosing schedule. |
|
less than 72 hours remaining before the next scheduled dose |
the missed dose should be skipped, the next dose should be administered on the regularly scheduled day, |
The day of weekly administration can be changed if necessary as long as the last dulaglutide dose was administered 3 or more days before.1
Enclosed Prescribing Information
TRULICITY® (dulaglutide) injection, for subcutaneous use, Lilly
1. Trulicity [package insert]. Indianapolis, IN: Eli Lilly and Company; 2020.
Glossary
GLP-1 RA = glucagon-like peptide-1 receptor agonist
Date of Last Review: June 10, 2020
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon - Fri, 9am - 7pm EST